Loading clinical trials...
Loading clinical trials...
This study aims to examine the clinical profile/anatomical characteristics and natural history of patients who subsequently fail screening for transcatheter mitral valve intervention (TMVI).
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Medstar Health Research Institute
NCT04688190 · Mitral Regurgitation, Mitral Valve Disease, and more
NCT07267117 · Heart Valve Disease, Mitral Valve (MV) Regurgitation, and more
NCT06025149 · Aortic Valve Disease, Mitral Valve Disease
NCT05655897 · Mitral Regurgitation, Degenerative Mitral Valve Disease
NCT04914468 · Mitral Valve Disease
Phoenix Cardiovascular Research Group
Phoenix, Arizona
Keck Hospital of USC
Los Angeles, California
MedStar Washington Hospital Center
Washington D.C., District of Columbia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions